6 Meridian’s United Therapeutics UTHR Stock Holding History

6 Meridian’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$224K	Buy	+1,036	New	+$203K	0.02%	338
2021 Q3	–	Sell	-1,214	Closed	-$218K	–	500
2021 Q2	$218K	Sell	1,214 -45	-4%	-$8.57K	0.02%	332
2021 Q1	$211K	Sell	1,259 -158	-11%	-$26.3K	0.02%	352
2020 Q4	$215K	Buy	+1,417	New	+$186K	0.02%	269

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

6 Meridian's UTHR Position: Q4 2021 in Review

6 Meridian opened a new position in United Therapeutics (UTHR) in Q4 2021: 1,036 shares worth $224K. The stake represents 0.02% of the portfolio and ranks #338 among its holdings. This is a return to the name: 6 Meridian previously reported a position in UTHR as recently as Q2 2021.

6 Meridian first reported a position in UTHR in Q4 2020 and has held it in 4 quarters since. 416 funds tracked by Wall St. Rank hold UTHR as of Q4 2021.

6 Meridian held 1,036 shares of United Therapeutics worth $224K as of Q4 2021.
United Therapeutics was a new 6 Meridian position in Q4 2021.
United Therapeutics made up 0.02% of 6 Meridian's portfolio in Q4 2021, its #338 holding.
6 Meridian first reported a position in United Therapeutics in Q4 2020 and has held it in 4 quarters since.
416 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.